Vanda Pharmaceuticals buy StockNews.com
Start price
30.03.24
/
50%
€3.92
Target price
30.03.25
-
Performance (%)
8.67%
End price
31.03.25
€4.26
Summary
This prediction ended on 31.03.25 with a price of €4.26. The BUY prediction by StockNews_com finished with a performance of 8.67%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 1.695% | 1.695% | 41.509% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten